Regulation of cell function by methionine oxidation and reduction

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

Regulation of cell function by methionine oxidation and reduction

Toshinori Hoshi* and Stefan H. Heinemann†

*Department of Physiology and Biophysics, The University of Iowa, BSB 5-660, Iowa City, IA 52242, USA and †Research Unit Molecular and Cellular Biophysics, Medical Faculty of the Friedrich Schiller University Jena, Drackendorfer Straße 1, D-07747 Jena, Germany

MS 11846 Received 30 October 2000; accepted after revision 28 November 2000.

ABSTRACT

Reactive oxygen species (ROS) are generated during normal cellular activity and may exist in excess in some pathophysiological conditions, such as inflammation or reperfusion injury. These molecules oxidize a variety of cellular constituents, but sulfur-containing amino acid residues are especially susceptible. While reversible cysteine oxidation and reduction is part of well-established signalling systems, the oxidation and the enzymatically catalysed reduction of methionine is just emerging as a novel molecular mechanism for cellular regulation. Here we discuss how the oxidation of methionine to methionine sulfoxide in signalling proteins such as ion channels affects the function of these target proteins. Methionine sulfoxide reductase, which reduces methionine sulfoxide to methionine in a thioredoxin-dependent manner, is therefore not only an enzyme important for the repair of age- or degenerative disease-related protein modifications. It is also a potential missing link in the post-translational modification cycle involved in the specific oxidation and reduction of methionine residues in cellular signalling proteins, which may give rise to activity-dependent plastic changes in cellular excitability.

Reactive oxygen species

Reactive oxygen species (ROS; different definitions of reactive oxygen species, free radicals and oxidants exist, see Halliwell & Gutteridge, 1999), such as the superoxide anion (O²^-�) and hydrogen peroxide (H₂O₂), are generated as part of the normal aerobic cellular existence and these reactive species in turn promote the production of many other molecules capable of inducing oxidative stress in cells. A delicate overall balance is normally maintained between the production and elimination of these oxidants using a variety of non-enzymatic and enzymatic processes. As shown below, however, it is becoming increasingly evident that cells may utilize small and/or local changes in oxidants/ROS concentrations as signals in cellular signal transduction (Suzuki et al. 1997; Fukagawa, 1999; Finkel, 2000).

Many ROS are free radicals with unpaired electrons, which are often very reactive and have very short half-life times. For example, starting from superoxide, the Fenton reaction produces H₂O₂ and then hydroxyl radical (OH^-�) using transition metal ions such as Fe³⁺/Fe²⁺. The hydroxyl radical is considered to be involved in the oxidative damage of various biomolecules. Although very powerful, these reactive radicals are expected to have small diffusion constant values, limiting their effective range. The hydroxyl radical has a life-time of only 2 ns and its diffusion radius is only 2 nm (Haugland, 1996). Less reactive species, however, may exert long-range effects within or even between cells. For example, NO, a weak radical, functions as an intercellular and an intracellular messenger (Jaffrey & Snyder, 1995; Yun et al. 1996; Squadrito & Pryor, 1998).

ROS, especially in the presence of other cofactors such as certain metal ions, are capable of oxidatively modifying a variety of cellular constituents (Halliwell & Gutteridge, 1999). The oxidative stress induced by these reactive agents could lead to lipid peroxidation, DNA damage and poly ADP-ribose synthetase activation, carbohydrate and protein damage. Lipid peroxidation resulting from oxidation of cholesterol and fatty acids may compromise the cell membrane integrity, and DNA damage may eventually lead to cell death or abnormal cell growth. The oxidant-mediated damages to DNA, lipids and proteins are likely to contribute to ageing, age-associated changes, and age-related degenerative diseases (Stadtman & Berlett, 1998).

Oxidation of amino acids

Amino acid residues in proteins represent one of the major targets of ROS and cellular oxidants. All amino acids can be oxidized, at least experimentally. These oxidative modifications include the polypeptide backbone as well as the amino acid side chain. Oxidative abstraction of a hydrogen atom from the $alpha$ carbon atom could lead to peptide bond cleavage (Stadtman & Berlett, 1999). Side chains of amino acids in proteins are readily oxidized to markedly alter the overall properties of the amino acids, thus potentially modifying protein function. A comprehensive list of the oxidatively modified amino acids is found elsewhere (Berlett & Stadtman, 1997; Halliwell & Gutteridge, 1999; Stadtman & Berlett, 1999). Different amino acids differ markedly in how easily their side chains are oxidatively modified. The sulfur-containing amino acids, cysteine and methionine, are especially sensitive to ROS-mediated oxidation, although the side chains of arginine, lysine, proline, histidine, tryptophan, and tyrosine are also known to be oxidatively modified (Berlett & Stadtman, 1997; Stadtman & Berlett, 1999). The overall extent of protein oxidation is often estimated by measuring the carbonyl content (Levine et al. 1994); however, some confounding issues have been raised regarding this assay (Halliwell & Gutteridge, 1999). A significant fraction of the total protein may be oxidized in humans (Stadtman, 1992).

Sulfur-containing amino acids: cysteine and methionine

Cysteine and methionine possess reactive sulfur-containing side chains that represent prime targets of ROS. Oxidation of cysteine and methionine residues in proteins are noteworthy in that the reactions can be physiologically reversible.

Oxidation of the thiol-containing cysteine, often promoted by the presence of trace amounts of metal ions such as Cu²⁺, Fe²⁺, Co²⁺ and Mn²⁺, leads to a variety of products including the sulfenic ion, disulfide and sulfonic ion (Finkel, 2000). Physiologically, the disulfide formation may be the most likely consequence of cysteine oxidation (Creighton, 1993). Disulfides can be easily reduced back to thiols using glutathione in vivo or dithiothreitol (DTT) in vitro. Reversible oxidation of cysteine has been postulated to work as an important cellular redox sensor in some proteins (Finkel, 2000). Stronger experimental oxidants may produce sulfonic and eventually sulfenic acid. Functional modulation of proteins in cellular excitability by cysteine oxidation has been suggested in many different experimental systems. Modulation of N-type inactivation of voltage-dependent potassium channels exemplifies a fast and reversible regulatory phenomenon mediated by oxidation of a specific cysteine residue in the amino-terminus of the channel protein (Kv1.4) (Ruppersberg et al. 1991) or the associated $beta$ -subunits (Rettig et al. 1994; Heinemann et al. 1995). The sensitivity of NMDA receptors in the brain to glutamate and H⁺ is also modulated by oxidation of two cysteine residues in NR1 subunits (Sullivan et al. 1994).

Oxidation of methionine

Methionine is oxidized to methionine sulfoxide (MetO, MeSOX, MetSO, or MsX) by the addition of an extra oxygen atom (Fig. 1). The presence of methionine sulfoxide has been documented in native proteins (e.g. Gao et al. 1998), indicating that oxidation of the methionine side chain is a physiologically relevant phenomenon. Unfortunately, the lack of an antibody specific to methionine sulfoxide has slowed elucidation of tissue distributions of methionine sulfoxide. In the presence of a strong oxidant, MetO is further oxidized to form methionine sulfone (MetO₂). However, the formation of MetO₂ may be of pathophysiological and/or experimental relevance only. Changes in the physical properties of the methionine side chain induced by oxidation are profound and are expected to alter protein function. The side chain of normal methionine is long, flexible, and non-polar (Richardson & Richardson, 1989). Although many methionine residues are excluded from the surface, some proteins may contain multiple exposed methionine residues (Levine et al. 1996). The side chain of methionine sulfoxide with the extra oxygen atom is stiffer and more polar than that of the methionine side chain. The hydrophobicity index of methionine sulfoxide has been estimated to be similar to that of lysine, a positively charged amino acid (Black & Mould, 1991). If one considers only the hydrophobicity aspect, this may be analogous to substitution of methionine with a charged amino acid. It should be noted, however, that the charge consideration alone is not likely to explain all the functional changes caused by methionine oxidation (Yin et al. 1999). The specific oxidation and reduction of methionine residues in proteins is expected to have profound consequences for protein function and may constitute a mechanism for protein regulation (see below). Furthermore, it has been suggested that the extent of cellular methionine oxidation is underestimated in part because the amino acid analysis based on the acid digestion is not suited for detection of methionine sulfoxide (Squier & Bigelow, 2000).

Methionine side chains are oxidized by a range of different ROS, such as O²^-�, H₂O₂, peroxynitrite (ONOO^-), or �OH. Experimentally, effects of methionine oxidation are often examined using oxidizing reagents that promote oxidation beyond the 'basal' level. Many methionine-specific reagents and oxidizing reactions have been reported in the literature. For example, dimethyl sulfoxide is a very specific methionine oxidizer, provided that at least 0�1 M and preferably 1 M HCl is present (Shechter et al. 1975). Unfortunately, many of these reaction conditions are not readily compatible with typical physiological investigations. Chloramine-T (Ch-T), H₂O₂ and t-butyl hydroperoxide have been used to infer the effects of methionine oxidation in physiological systems (see below). H₂O₂ and t-butyl hydroperoxide could be used as specific methionine oxidizers especially if the halide concentration is negligible (Keck, 1996). H₂O₂ may be considered as a relatively physiological oxidizer since it may mimic the methionine oxidation pattern found in vivo (Gao et al. 1998; Squier & Bigelow, 2000). Some information about the target methionine residues could be obtained by comparing the effects of H₂O₂ and t-butyl hydroperoxide. t-Butyl hydroperoxide may specifically modify exposed surface methionine residues whereas H₂O₂ attacks both exposed and buried methionine residues (Keck, 1996). In addition to methionine, these agents may also oxidize cysteine, and some caution is warranted when interpreting the results. It may also be prudent to carefully control the concentrations of contaminating divalent and trivalent metal ions when performing the experiments using these oxidizing agents since production of radicals may depend on the availability of these metal ions. Seemingly conflicting results could be explained by the presence of different concentrations of contaminating ions.

The changes in the physical and chemical properties associated with oxidation of methionine summarized above could lead to discernible changes in protein function and cell physiology. These changes include loss of function (degeneration) and regulation of cell function. Some examples to illustrate these changes are discussed later in this article. We will emphasize the role of methionine oxidation as a regulator of cell function. However, there are many proteins that harbour methionine residues at their surface and oxidation of these residues does not seem to impair function. Therefore, it can be speculated that the cyclic oxidation/reduction of such methionine residues may also constitute an endogenous system with local antioxidative capacity (Levine et al. 1996).

Methionine sulfoxide reductase (MSRA)

As is the case with reduction of oxidized cysteine, MetO can be physiologically reduced back to methionine. Unlike reduction of disulfides, the reducing reaction of MetO to methionine is catalysed by the enzyme peptide methionine sulfoxide reductase (MSRA) using thioredoxin in vivo or DTT in vitro (Moskovitz et al. 1996; Fig. 1). A recent study suggests that MSRA may preferentially reduce L-methionine sulfoxide (Sharov et al. 1999). MSRA is a relatively small cytosolic enzyme found in a variety of organisms from bacteria (Moskovitz et al. 1995) to plants (Sadanandom et al. 2000) and mammals (Moskovitz et al. 1996), including humans (Kuschel et al. 1999). The amino acid sequence is well conserved among different species; the Escherichia coli and human MSRA amino acid sequences are approximately 60 % identical with notable differences occurring in the distal N- and C-terminal segments. The crystal structure of MSRA has become available recently (Lowther et al. 2000b; Tete-Favier et al. 2000) and the active site of this enzyme has been identified by mutagenesis (Lowther et al. 2000a; Moskovitz et al. 2000). In humans, one msrA gene located on chromosome 8 is known; however, no information is available about the genomic organization of the gene. Such information will be undoubtedly helpful in the investigation of any potential role of MSRA in age-related changes. The results obtained from plants suggest that multiple genes could exist (Sadanandom et al. 2000).

View larger version
[in this window]
[in a new window]

Figure 1. Oxidation and reduction of methionine residues
The amino acid methionine (Met) is easily oxidized to methionine sulfoxide (MetO) in the presence of mild oxidants. A second oxidation step, requiring stronger oxidants such as chloramine-T, results in methionine sulfone (MetO₂). While MetO₂ is stable under physiological conditions, MetO can be reduced back to Met by means of the enzyme peptide methionine sulfoxide reductase (MSRA). To maintain catalytic activity, MSRA needs an electron acceptor. Under physiological conditions MSRA is coupled via thioredoxin, thioredoxin reductase, and NADPH to the cellular redox system. The activity of MSRA may also be subject to cellular regulation by thus far unidentified cofactors.

MSRA is differentially expressed among different tissues, indicating that the enzyme may have specific physiological functions. In rats, high immunocytochemical staining was found in liver, kidney, heart and brain, especially in the cerebellum (Moskovitz et al. 1996). In adult human tissues, a high MSRA mRNA level is observed in liver, kidney, heart and brain (Kuschel et al. 1999). High expression in liver and kidney is consistent with the notion that MSRA may participate as an anti-oxidant enzyme to repair 'aged' proteins as these detoxifying organs are steadily exposed to oxidative stress. The overall expression level in the brain is also high and the heterogeneous expression pattern is evident within the brain. MSRA RNA is most abundantly present in the cerebellum, followed by the hippocampus and the temporal lobe. In contrast, little RNA was detected in pons and substantia nigra. It is interesting to note that, in Parkinson's disease, the neurons in the substantia nigra are selectively lost and that ROS is frequently cited as a contributing factor (e.g. Cohen, 1999). The presence of MSRA in selected regions of the brain suggests that methionine oxidation may have a role in neuronal function.

Comparison of the RNA tissue distribution in human adult and embryonic tissues indicates that expression or activity of MSRA may be developmentally regulated (Gabbita et al. 1999; Kuschel et al. 1999). In general, fetal tissue appears to express much less MSRA mRNA than the corresponding adult tissue. A notable exception is liver, where an expression level in the fetal tissue similar to that of the adult tissue is observed. This observation correlates with the fact that fetal liver is fully functional before term. As explored more fully below, there are some indications that the MSRA activity may decrease in some conditions often associated with ageing. However, currently there is no systematic information available regarding how the MSRA expression levels in different tissues change with age.

Interestingly, the MSRA mRNA is not readily detected in tumour cell lines (Kuschel et al. 1999). For example, leukaemia or lymphoma cell lines do not express mRNA coding for MSRA, whereas normal peripheral blood leukocytes express this gene. It is not clear whether the absence of MSRA in these tumour cells represents a cause or consequence of the cancerogeneity. Further work is obviously required to elucidate this intriguing question.

Although it is established that MSRA is a cytoplasmic protein, its subcellular distribution has not been demonstrated. It is reasonable to suspect that MSRA may be localized in those areas where the ROS concentrations may be high, such as mitochondria. However, no published report exists that addresses this issue. In plants, two variants of MSRA with different subcellular localization patterns are known to exist; one form is distributed diffusely in the cytoplasm and the other appears to be localized in plastids (Sadanandom et al. 2000).

Implications in pathophysiological phenomena

The irreversible oxidation of methionine residues in proteins to MetO₂ should lead in many cases to the loss of function and therefore to pathophysiological situations. Similarly, methionine oxidation to MetO in combination with an insufficient reduction capacity should have similar consequences. Therefore, methionine oxidation is often discussed as one of the sources for physiological dysfunctions in several age-associated changes and degenerative diseases. In addition, oxidation of methionine residues resulting in transient or long-lasting alterations of protein functions is expected to occur under situations of acute local production of excess ROS.

Acute processes

All processes that lead to an excess production of free radicals could result in the oxidation of methionine residues in proteins. Several such processes are described, but only in some cases has the direct involvement of methionine oxidation been documented. One example with important clinical relevance is reperfusion injury (Chan, 1996). Subsequent to ischaemic episodes, in almost all organs but prominently in brain and cardiac tissue, reperfusion results in the excess generation of ROS and cell damage. Protein damage by oxidation also plays an important role in inflammatory processes (Winrow et al. 1993). The oxidative bursts produced by neutrophils and macrophages in the immune response are supposed to inactivate pathogens, but chronic activity of this defense system, as in rheumatoid arthritis and inflammatory bowel disease, can cause cell damage and pain. Part of the destructive power of oxidative stress in rheumatoid arthritis (Chidwick et al. 1991) as well as in emphysema (Janoff et al. 1979; Johnson & Travis, 1979) may arise from the inhibition of $alpha$ 1-antiproteinase. A conserved methionine residue is responsible for this oxidation-dependent inactivation; incubation of oxidized $alpha$ -1 protease inhibitor with MSRA restores its activity to suppress proteases (Mohsenin & Gee, 1989).

Long-term degenerative effects and ageing

In various systems, the intracellular level of oxidized protein increases with age (for review see Stadtman & Berlett, 1999). Examples are the human brain (Carney et al. 1991; Smith et al. 1991), human eye lens (Garland et al. 1988; Garland, 1991) and human erythrocytes (Oliver et al. 1987). The total amount of oxidatively modified proteins is estimated to be up to 50 % for an 80-year-old human (Starke-Reed & Oliver, 1989; Stadtman, 1992). Animal models show that old animals are more susceptible to oxidative stress and the life span of animals correlates with the amount of oxidized protein (Yu et al. 1998). The latter aspect could be related to methionine oxidation since a yeast strain overexpressing MSRA was shown to exhibit a higher resistance against oxidative stress. In addition, T-lymphocytes are more resistant to H₂O₂ after overexpression of MSRA (Moskovitz et al. 1998).

While the oxidative damage of proteins during the process of ageing or in age-related changes is well established, it remains a speculation whether or not the enzyme-mediated decrease of the oxidation level will alleviate the problems associated with age-related changes and extended life span in human beings. Experimental findings indicate that this may indeed be possible. In model animals, over-expression/ activation of 'anti-oxidant' enzymes, such as superoxide dismutase, does increase the life span (Parkes et al. 1998; Sun & Tower, 1999; Tower, 2000; Melov et al. 2000). However, even if the systematic reduction of the oxidation level, e.g. by the intake of antioxidants, does not overcome apoptotic processes which may ultimately determine the life span, they may increase the quality of life of the elderly by reducing common age-related changes. Older gerbils with more oxidized proteins in the brain perform poorly in a maze test, but a free radical scavenger decreases the oxidized protein level and also improves the maze performance (Carney et al. 1991). Several degenerative diseases have been discussed in relation to oxidation of proteins such as Parkinson's disease (Cohen, 1999), Alzheimer's disease (Smith et al. 1996) and eye lens cataract (Garland et al. 1988; Garland, 1991). In such processes the oxidation and reduction of methionine and the expression of MSRA may play an important role. In fact, in patients with Alzheimer's disease decreased levels of MSRA were found in brain samples (Gabbita et al. 1999). These results suggest that overexpression of MSRA may lead to beneficial consequences.

Modulation of cellular excitability by methionine oxidation

It is only recently that some examples of the modulatory potential of methionine oxidation in the regulation of cellular excitability have been demonstrated. Here, two cases involving voltage-gated K⁺ channels and calmodulin, both of which are involved in cellular excitability, are discussed. Voltage-gated K⁺ channels play critical roles in cellular excitability, generally exerting an inhibitory influence. These channels are often a major determinant of the action potential threshold and the shape of the action potential. Drosophila Shaker channels, which give rise to transient A-type K⁺ currents, were the first voltage-gated K⁺ channels whose DNA sequences were determined. ShC/B channels represent one of the many variants of the Shaker channel. When heterologously expressed in Xenopus oocytes by injection of in vitro transcribed RNA, the macroscopic inactivation time course mediated by the ball and chain N-type inactivation of ShC/B channels is extremely variable (Fig. 2; Aldrich et al. 1990; Ciorba et al. 1997; Ciorba et al. 1999; Kuschel et al. 1999). Other variants of the Shaker channel such as ShB do not exhibit similar variability. Large variability like that observed with ShC/B channels often hinders biophysical investigations of ion channels. However, the presence of variability does indicate that a regulatory mechanism is operative. At the single-channel level, two modes of inactivation gating are often observed from one channel protein. A single ShC/B channel may display very rapid N-type inactivation in response to some pulses but it may also show very slow or no inactivation. The N-type inactivation kinetics of ShC/B channels was slowed by application of the oxidant Ch-T or H₂O₂, and mutagenesis indicated that substitution of a methionine residue at position 3 in the N-terminal ball region of the channel with leucine, which is less readily oxidized, largely eliminated the inactivation variability and reduced the oxidant sensitivity. The distal N-terminal segment of the Shaker channel stabilizes the N-type inactivated state via hydrophobic interactions and introduction of a polar residue destabilizes the inactivated state (Hoshi et al. 1990; Zagotta et al. 1990; Murrell-Lagnado & Aldrich, 1993). Oxidation of Met3 to MetO, which is considerably more polar than Met, is expected to destabilize the inactivated state. Using the synthetic peptide approach that allows the defined incorporation of non-natural amino acids, such as MetO, Ciorba et al. (1997) found that the inactivation time course was drastically slowed by the presence of MetO at position 3.

View larger version
[in this window]
[in a new window]

Figure 2. Regulation of potassium channels by methionine oxidation and reduction
A, schematic diagram of a potassium channel complex indicating the N-terminal ends of three of the four $alpha$ -subunits that form in some channel types inactivating structures, i.e. protein segments that occlude the permeation pore upon channel activation. Recent studies suggest that the N-terminal segment of the $alpha$ -subunit may also contain a structure that could be described as a hanging gondola (Gulbis et al. 2000; Kobertz et al. 2000) but for the sake of simplicity the gondola-like structure is not included in the diagram. B, in Shaker C/B channels the amino acid residue at position 3 is methionine. With this residue in the reduced form, the channels exhibit rapid N-type inactivation; upon oxidation to MetO rapid inactivation is impaired (Ciorba et al. 1997). C, superposition of current traces obtained from different Xenopus oocytes after heterologous expression of Shaker C/B channels; depolarization to +40 mV. The time course of inactivation obtained in whole cells shows a very strong scatter indicating cell-to-cell variability of the amount of oxidized methionine. D, upon coexpression with human MSRA the time course of inactivation is much faster and the variability is diminished.

Furthermore, coexpression of the ShC/B channel with bovine or human MSRA drastically reduced the inactivation variability and accelerated the overall inactivation time course (Ciorba et al. 1997; Kuschel et al. 1999). Incubation with MSRA also restored the ability of the inactivation peptide with MetO at position 3 to induce inactivation (Ciorba et al. 1997). These observations are consistent with the notion that MSRA acts as a critical regulator of the ShC/B channel inactivation kinetics.

Many ROS and RNS (reactive nitrogen species) are capable of oxidizing methionine to MetO. The weak radical NO may react with O^-� to form ONOO^- and may promote methionine oxidation (Vogt, 1995). Indeed, ONOO^- oxidizes methionine residues in glutamine synthetase and bovine serum albumin to MetO in a CO₂- and pH-dependent manner (Tien et al. 1999). Application of NO donors to ShC/B channels or activation of nNOS (neuronal nitric oxide synthase) slows the inactivation time course in a manner similar to that induced by Ch-T (Ciorba et al. 1999) and suggests that methionine oxidation could be one of the mechanisms by which NO regulates its effectors.

Chen et al. (2000) showed that another kinetic property of Shaker channels was also regulated by methionine oxidation. In many voltage-gated K⁺ channels, a distinct, often slower, inactivation process termed 'P/C-type inactivation' exists (Hoshi et al. 1991; Loots & Isacoff, 1998). This inactivation involves constriction of the external mouth of the channel pore (Yellen, 1998). Chen et al. (2000) found that the time course of P/C-type inactivation in a Shaker channel without N-type inactivation (ShB $Delta$ 6-46:T449S) had two kinetic components and that their relative fractions were quite variable among different patches. Application of the oxidant H₂O₂, patch excision and high O₂ up-regulated the fast component, accelerating the overall inactivation kinetics. Substitution of a methionine residue in the pore segment of the channel with less readily oxidized leucine essentially eliminated the oxidant sensitivity, suggesting that oxidation of this methionine residue acts as a control switch for the two components in P/C-type inactivation.

One of the logical questions is, of course, whether other channels and transporters, especially in humans, are regulated by oxidation of methionine. There are many indications in the literature that suggest that this is indeed the case. Numerous studies have shown that application of oxidants, such as H₂O₂, has dramatic effects on functional properties of ion channels and transporters. Some of these effects are not easily explained by reversible oxidation of cysteine. For example, redox regulation of Na⁺-Ca²⁺ exchangers does not appear to involve cysteine (Santacruz-Toloza et al. 2000). Large-conductance Ca²⁺-activated K⁺ channels are also redox regulated; some studies showed that oxidation enhanced while others showed that oxidation decreased the channel activity (Dichiara & Reinhart, 1997; Thuringer & Findlay, 1997; Wang et al. 1997; Barlow & White, 1998; Ahern et al. 1999). It is possible that these effects may represent the combined effects of oxidation of cysteine and methionine residues. Using Ch-T as an oxidizing agent, Quinonez et al. (1999) suggest that at least two methionine residues in voltage-gated Na⁺ channels could be oxidized to alter fast inactivation. In Na⁺ channels, the short segment located between the domain III-IV linker (IFM) plays an important role in inactivation (Catterall, 2000). The methionine residue located in this segment is considered to stabilize the inactivation state via hydrophobic interactions (Rohl et al. 1999). It may be speculated that oxidation of this methionine to MetO, which disrupts the hydrophobic interactions, will have a noticeable impact on the inactivation of Na⁺ channels and this could account for the observation that Ch-T slowed the inactivation time course (Quinonez et al. 1999).

Another set of important examples of oxidative regulation of cellular excitability concerns the Ca²⁺-binding protein calmodulin (CaM). This protein is involved in many cellular processes as it controls the function of a large number of enzymes, ion channels, pumps, and other signalling proteins, many of them in a Ca²⁺-dependent manner. CaM loses its conformational stability upon Met oxidation (Gao et al. 1998), but the 'repair' of oxidized CaM by MSRA can restore functionality (e.g. Sun et al. 1999). Thus, by this mechanism, the selective methionine oxidation of CaM (human CaM does not have Cys residues) and its reduction by MSRA constitutes a regulatory system by which the activity of numerous cellular signalling systems can be controlled. The best studied is the function of Ca²⁺-ATPases, which are sensitive to oxidative stress by means of CaM interactions (Gao et al. 1998; Squier & Bigelow, 2000). CaM with the C-terminal methionine residues oxidized loses the ability to activate the plasma membrane Ca²⁺-ATPase (Yao et al. 1996). Recent studies have shown that the Ca²⁺-sensitivity of many ion channels is conferred by CaM (Levitan, 1999), e.g. NMDA-activated channels (Zhang et al. 1998), small-conductance and intermediate-conductance Ca²⁺-activated K⁺ channels (Xia et al. 1998; Fanger et al. 1999), voltage-dependent Ca²⁺ channels (Lee et al. 1999; Peterson et al. 1999), and ether à go-go K⁺ channels (Schönherr et al. 2000). Therefore, methionine oxidation could potentially modulate these channels indirectly via CaM.

Activity-dependent modulation via oxidation

The examples discussed above suggest that the reversible oxidation of amino acid residues could have a marked impact on protein function. Considering that functionally active cells are likely to be metabolically active, leading to a greater production of ROS, it can be postulated that amino acid oxidation could be used to mediate activity-dependent modulation of cellular function (Fig. 3). For example, a burst of electrical activity in a neuron may increase intracellular Ca²⁺ concentration and may stimulate the metabolism, leading to a higher ROS level. Activation of NMDA receptors may also result in the production of superoxide (Lafon-Cazal et al. 1993). These ROS may in turn oxidize the susceptible cysteine and methionine residues in cellular proteins. The oxidized cysteine residues may be reduced as soon as the cellular redox state is restored. In contrast, the affected methionine residues stay oxidized until reduced by the action of MSRA. Thus, cysteine oxidation is well suited to mediate short-term modulation while methionine oxidation may mediate longer-lasting modulation. Yermalaieva et al. (2000) showed that oxidation could act as a coincidence sensor to enhance neuronal Ca²⁺ signalling in an activity-dependent manner. It was only when depolarization and oxidative stress were coupled that subsequent Ca²⁺ signals induced by depolarization were enhanced.

View larger version
[in this window]
[in a new window]

Figure 3. Activity-dependent oxidative regulation
Simplified scheme illustrating activity-dependent regulation of cellular excitability. Increased cellular activity requires a higher ATP consumption and therefore results in an increased production of O²^-� in the mitochondrial respiratory chain. O²^-� is dismutated to form H₂O₂ by the superoxide dismutase (SOD). H₂O₂ is degraded by antioxidant enzymes such as catalase (Cat) or glutathione peroxidase. In addition, �OH radicals are formed from H₂O₂ via the Fenton reaction in the presence of transitional metal ions (Me). Stimulated by Ca²⁺-CaM and the activation of calcineurin, nitric oxide synthase (NOS) generates NO� from L-arginine. NO� is combined with O²^-� to form the highly reactive peroxynitrite (ONOO^-). In addition, the highly diffusible gas NO� can affect neighbouring cells and therefore acts, for example, as a retrograde messenger. The reactive oxygen and nitrogen species (ROS, RNS, darker blue shading) can now result in protein oxidation or nitration. Of particular interest are signalling proteins that are coupled to the intracellular Ca²⁺ level or the membrane voltage, i.e. Ca²⁺-permeable ion channels, voltage-gated K⁺ channels, Ca²⁺-ATPases or proteins that are functionally regulated by CaM. Cyclic oxidation and reduction of methionine residues in such proteins may close feedback loops in which increased cellular activity stimulates either increased or decreased cellular excitability.

The link between the cellular electrical activity and ROS may be provided by mitochondria. They synthesize ATP to meet cellular energy requirements and thereby represent a major source of cellular ROS (Halliwell & Gutteridge, 1999). Mitochondria are also postulated to actively participate in the regulation of cytosolic Ca²⁺, contributing to the regulation of neurotransmitter release (Rahamimoff et al. 1999; Berridge et al. 2000). The synthesis of ROS by mitochondria is increased by, among others, an increase in cytosolic Ca²⁺ (Dykens, 1994; Kowaltowski et al. 1995). Therefore, influx of Ca²⁺ into the cytoplasm from the external medium, such as that expected during a burst of action potentials, increases the overall cellular ROS and oxidant levels. The ROS/oxidant production in mitochondria is expected to reflect, at least to some extent, the functional activity history of the cell. This may preferentially be manifested by the methionine oxidation of proteins in or at mitochondria.

The regulation of protein function by oxidation of methionine to MetO and the reverse reaction catalysed by MSRA may have features analogous to phosphorylation/ dephosphorylation mediated by various kinases and phosphatases. In phosphorylated proteins, some consensus amino acid sequence motifs with some predictive power could be defined. At present, no such consensus sequence for methionine oxidation is known. Obviously, exposed residues are more likely to be oxidized and it is plausible that those methionine residues near metal binding sites are preferentially oxidized (Yao et al. 1996). Another potential mechanism of methionine oxidation specificity may be clustering of the target proteins with ROS-generating elements. For example, NOS is found to colocalize with several other proteins, including K⁺ channels and glutamate receptors (Kim et al. 1995; Brenman et al. 1996; Niethammer et al. 1996; Sheng, 1996). Since NO is capable of promoting methionine oxidation, those proteins located near NOS are more likely to be regulated by methionine oxidation. The availability of certain metal ions, such as Fe²⁺ and Cu²⁺, constitutes another mechanism to confer specificity. The reduction mechanism mediated by MSRA is also subject to further regulation. As stated above, there may be multiple variants of the enzyme with different subcellular and tissue distributions. Developmental regulation of the MSRA activity is already noted above. Since MSRA reduces MetO in a thioredoxin-dependent manner, those factors that alter the thioredoxin availability could indirectly regulate the MSRA action.

Conclusion

Besides the prominent role of methionine oxidation and enzyme-mediated reduction in ageing and age-related degenerative diseases, increasing evidence is being compiled supporting the role of methionine oxidation and reduction in the regulation of cell function under physiological conditions. Several crucial signalling proteins are functionally altered by methionine oxidation and reduction, giving rise to activity-dependent long-lasting post-translational modifications. Thus, the functional roles of the oxidation of methionine residues and their reduction, catalysed by methionine sulfoxide reductase, need to be examined as a potential regulator of cellular function in a variety of physiological systems.

T.H. was supported in part by NIH grants GM 57654, HL 64645 and HL 14388, and S.H.H. was supported in part by DFG (He2993/1). We thank A. Hansel for comments on the manuscript.

Corresponding author

S. H. Heinemann: Research Unit Molecular and Cellular Biophysics, Medical Faculty of the Friedrich Schiller University Jena, Drackendorfer Straße 1, D-07747 Jena, Germany.

Email: stefan.h.heinemann{at}uni-jena.de

This article has been cited by other articles:

Y. Pan, J. Weng, Y. Cao, R. C. Bhosle, and M. Zhou
Functional Coupling between the Kv1.1 Channel and Aldoketoreductase Kv{beta}1
J. Biol. Chem., March 28, 2008; 283(13): 8634 - 8642.
[Abstract] [Full Text] [PDF]

C. Achilli, A. Ciana, A. Rossi, C. Balduini, and G. Minetti
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes
J. Leukoc. Biol., January 1, 2008; 83(1): 181 - 189.
[Abstract] [Full Text] [PDF]

J. Lu, E.-H. Chew, and A. Holmgren
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
PNAS, July 24, 2007; 104(30): 12288 - 12293.
[Abstract] [Full Text] [PDF]

G. Wang, C. Strang, P. J. Pfaffinger, and M. Covarrubias
Zn2+-dependent Redox Switch in the Intracellular T1-T1 Interface of a Kv Channel
J. Biol. Chem., May 4, 2007; 282(18): 13637 - 13647.
[Abstract] [Full Text] [PDF]

J. Choi, M. C. Sullards, J. A. Olzmann, H. D. Rees, S. T. Weintraub, D. E. Bostwick, M. Gearing, A. I. Levey, L.-S. Chin, and L. Li
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
J. Biol. Chem., April 21, 2006; 281(16): 10816 - 10824.
[Abstract] [Full Text] [PDF]

W. Ulbricht
Sodium Channel Inactivation: Molecular Determinants and Modulation
Physiol Rev, October 1, 2005; 85(4): 1271 - 1301.
[Abstract] [Full Text] [PDF]

A.-L. Bulteau, K. C. Lundberg, M. Ikeda-Saito, G. Isaya, and L. I. Szweda
Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion
PNAS, April 26, 2005; 102(17): 5987 - 5991.
[Abstract] [Full Text] [PDF]

H. M. Romero, B. S. Berlett, P. J. Jensen, E. J. Pell, and M. Tien
Investigations into the Role of the Plastidial Peptide Methionine Sulfoxide Reductase in Response to Oxidative Stress in Arabidopsis
Plant Physiology, November 1, 2004; 136(3): 3784 - 3794.
[Abstract] [Full Text] [PDF]

Q. Xu, M. P. Belcastro, S. T. Villa, R. D. Dinkins, S. G. Clarke, and A. B. Downie
A Second Protein L-Isoaspartyl Methyltransferase Gene in Arabidopsis Produces Two Transcripts Whose Products Are Sequestered in the Nucleus
Plant Physiology, September 1, 2004; 136(1): 2652 - 2664.
[Abstract] [Full Text] [PDF]

N. K. Fukagawa and R. A. Galbraith
Advancing Age and Other Factors Influencing the Balance between Amino Acid Requirements and Toxicity
J. Nutr., June 1, 2004; 134(6): 1569S - 1574S.
[Abstract] [Full Text] [PDF]

N. J. H. Cotton, B. Stoddard, and W. W. Parson
Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase
J. Biol. Chem., May 28, 2004; 279(22): 23710 - 23718.
[Abstract] [Full Text] [PDF]

U. Bechtold, D. J. Murphy, and P. M. Mullineaux
Arabidopsis Peptide Methionine Sulfoxide Reductase2 Prevents Cellular Oxidative Damage in Long Nights
PLANT CELL, April 1, 2004; 16(4): 908 - 919.
[Abstract] [Full Text] [PDF]

J. Choi, A. I. Levey, S. T. Weintraub, H. D. Rees, M. Gearing, L.-S. Chin, and L. Li
Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases
J. Biol. Chem., March 26, 2004; 279(13): 13256 - 13264.
[Abstract] [Full Text] [PDF]

G. H. Coombs, G. D. Westrop, P. Suchan, G. Puzova, R. P. Hirt, T. M. Embley, J. C. Mottram, and S. Muller
The Amitochondriate Eukaryote Trichomonas vaginalis Contains a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System
J. Biol. Chem., February 13, 2004; 279(7): 5249 - 5256.
[Abstract] [Full Text] [PDF]

O. Yermolaieva, R. Xu, C. Schinstock, N. Brot, H. Weissbach, S. H. Heinemann, and T. Hoshi
Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation
PNAS, February 3, 2004; 101(5): 1159 - 1164.
[Abstract] [Full Text] [PDF]

V. K. Singh and J. Moskovitz
Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress
Microbiology, October 1, 2003; 149(10): 2739 - 2747.
[Abstract] [Full Text] [PDF]

				C. Achilli, A. Ciana, A. Rossi, C. Balduini, and G. Minetti Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes J. Leukoc. Biol., January 1, 2008; 83(1): 181 - 189. [Abstract] [Full Text] [PDF]

				J. Lu, E.-H. Chew, and A. Holmgren Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide PNAS, July 24, 2007; 104(30): 12288 - 12293. [Abstract] [Full Text] [PDF]

				G. Wang, C. Strang, P. J. Pfaffinger, and M. Covarrubias Zn2+-dependent Redox Switch in the Intracellular T1-T1 Interface of a Kv Channel J. Biol. Chem., May 4, 2007; 282(18): 13637 - 13647. [Abstract] [Full Text] [PDF]

				J. Choi, M. C. Sullards, J. A. Olzmann, H. D. Rees, S. T. Weintraub, D. E. Bostwick, M. Gearing, A. I. Levey, L.-S. Chin, and L. Li Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases J. Biol. Chem., April 21, 2006; 281(16): 10816 - 10824. [Abstract] [Full Text] [PDF]

				W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF]

				A.-L. Bulteau, K. C. Lundberg, M. Ikeda-Saito, G. Isaya, and L. I. Szweda Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion PNAS, April 26, 2005; 102(17): 5987 - 5991. [Abstract] [Full Text] [PDF]

				H. M. Romero, B. S. Berlett, P. J. Jensen, E. J. Pell, and M. Tien Investigations into the Role of the Plastidial Peptide Methionine Sulfoxide Reductase in Response to Oxidative Stress in Arabidopsis Plant Physiology, November 1, 2004; 136(3): 3784 - 3794. [Abstract] [Full Text] [PDF]

				Q. Xu, M. P. Belcastro, S. T. Villa, R. D. Dinkins, S. G. Clarke, and A. B. Downie A Second Protein L-Isoaspartyl Methyltransferase Gene in Arabidopsis Produces Two Transcripts Whose Products Are Sequestered in the Nucleus Plant Physiology, September 1, 2004; 136(1): 2652 - 2664. [Abstract] [Full Text] [PDF]

				N. K. Fukagawa and R. A. Galbraith Advancing Age and Other Factors Influencing the Balance between Amino Acid Requirements and Toxicity J. Nutr., June 1, 2004; 134(6): 1569S - 1574S. [Abstract] [Full Text] [PDF]

				N. J. H. Cotton, B. Stoddard, and W. W. Parson Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase J. Biol. Chem., May 28, 2004; 279(22): 23710 - 23718. [Abstract] [Full Text] [PDF]

Ahern, G. P., Hsu, S. F. & Jackson, M. B. (1999). Direct actions of nitric oxide on rat neurohypophysial K⁺ channels. The Journal of Physiology 520, 165-176	[Abstract/Full Text]
Aldrich, R. W., Hoshi, T. & Zagotta, W. N. (1990). Differences in gating among amino-terminal variants of Shaker potassium channels. Cold Spring Harbor Symposia on Quantitative Biology 55, 19-27	[Medline]
Barlow, R. S. & White, R. E. (1998). Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. American Journal of Physiology 275, H1283-1289	[Medline]
Berlett, B. S. & Stadtman, E. R. (1997). Protein oxidation in aging, disease, and oxidative stress. Journal of Biological Chemistry 272, 20313-20316	[Full Text]
Berridge, M. J., Lipp, P. & Bootman, M. D. (2000). The versatility and universality of calcium signalling. Nature Reviews/Molecular Cell Biology 1, 11-21.
Black, S. D. & Mould, D. R. (1991). Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications. Analytical Biochemistry 193, 72-82	[Medline]
Brenman, J. E., Christopherson, K. S., Craven, S. E., McGee, A. W. & Bredt, D. S. (1996). Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. Journal of Neuroscience 16, 7407-7415	[Abstract/Full Text]
Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991). Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha- phenylnitrone. Proceedings of the National Academy of Sciences of the USA 88, 3633-3636	[Abstract]
Catterall, W. A. (2000). From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13-25	[Medline]
Chan, P. H. (1996). Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129	[Abstract/Full Text]
Chen, J., Avdonin, V., Ciorba, M. A., Heinemann, S. H. & Hoshi, T. (2000). Acceleration of P/C-type inactivation in voltage-gated K⁺ channels by methionine oxidation. Biophysical Journal 78, 174-187	[Abstract/Full Text]
Chidwick, K., Winyard, P. G., Zhang, Z., Farrell, A. J. & Blake, D. R. (1991). Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 50, 915-916	[Abstract]
Ciorba, M. A., Heinemann, S. H., Weissbach, H., Brot, N. & Hoshi, T. (1997). Modulation of potassium channel function by methionine oxidation and reduction. Proceedings of the National Academy of Sciences of the USA 94, 9932-9937	[Abstract/Full Text]
Ciorba, M. A., Heinemann, S. H., Weissbach, H., Brot, N. & Hoshi, T. (1999). Regulation of voltage-dependent K⁺ channels by methionine oxidation: effect of nitric oxide and vitamin C. FEBS Letters 442, 48-52	[Medline]
Cohen, G. (1999). Oxidative stress and Parkinson's disease. In Reactive Oxygen Species in Biological Systems: an Interdisciplinary Approach, ed. Gilbert D. L. & Colton, C. A., pp. 593-608. Luwer/Plenum, New York.
Creighton, T. E. (1993). Proteins: Structures and Molecular Properties. W. H. Freeman, New York.
Dichiara, T. J. & Reinhart, P. H. (1997). Redox modulation of hslo Ca²⁺-activated K⁺ channels. Journal of Neuroscience 17, 4942-4955	[Abstract/Full Text]
Dykens, J. A. (1994). Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca²⁺ and Na⁺: implications for neurodegeneration. Journal of Neurochemistry 63, 584-591	[Abstract]
Fanger, C. M., Ghanshani, S., Logsdon, N. J., Rauer, H., Kalman, K., Zhou, J., Beckingham, K., Chandy, K. G., Cahalan, M. D. & Aiyar, J. (1999). Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. Journal of Biological Chemistry 274, 5746-5754	[Abstract/Full Text]
Finkel, T. (2000). Redox-dependent signal transduction. FEBS Letters 476, 52-54	[Medline]
Fukagawa, N. K. (1999). Aging: is oxidative stress a marker or is it causal? Proceedings of the Society for Experimental Biology and Medicine 222, 293-298	[Abstract/Full Text]
Gabbita, S. P., Aksenov, M. Y., Lovell, M. A. & Markesbery, W. R. (1999). Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. Journal of Neurochemistry 73, 1660-1666	[Abstract/Full Text]
Gao, J., Yin, D. H., Yao, Y. H., Sun, H. Y., Qin, Z. H., Schoneich, C., Williams, T. D. & Squier, T. C. (1998). Loss of conformational stability in calmodulin upon methionine oxidation. Biophysical Journal 74, 1115-1134	[Abstract/Full Text]
Garland, D. L. (1991). Ascorbic acid and the eye. American Journal of Clinical Nutrition 54, 1198S-1202S	[Abstract]
Garland, D., Russell, P. & Zigler, J. S. (1988). The oxidative modification of lens proteins. In Oxygen Radicals in Biology and Medicine, ed. Simic, M. G., Taylor, K. S., Ward, J. F. & von Sontag V., pp. 347-353. Plenum Press, New York.
Gulbis, J. M., Zhou, M., Mann, S. & MacKinnon, R. (2000). Structure of the cytoplasmic beta subunit-T1 assembly of voltage- dependent K⁺ channels. Science 289, 123-127	[Abstract/Full Text]
Halliwell, B. & Gutteridge, J. M. C. (1999). Free Radicals in Biology and Medicine, 3rd edn. Oxford University Press, New York.
Haugland, R. P. (1996). Handbook of Fluorescent Probes and Research Chemicals. Molecular Probes, Eugene, OR, USA.
Heinemann, S. H., Rettig, J., Wunder, F. & Pongs, O. (1995). Molecular and functional characterization of a rat brain Kv $beta$ 3 potassium channel subunit. FEBS Letters 377, 383-389	[Medline]
Hoshi, T., Zagotta, W. N. & Aldrich, R. W. (1990). Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 250, 533-538	[Medline]
Hoshi, T., Zagotta, W. N. & Aldrich, R. W. (1991). Two types of inactivation in Shaker K⁺ channels: effects of alterations in the carboxy-terminal region. Neuron 7, 547-556	[Medline]
Jaffrey, S. R. & Snyder, S. H. (1995). Nitric oxide: a neural messenger. Annual Review of Cell and Developmental Biology 11, 417-440	[Abstract]
Janoff, A., Carp, H., Lee, D. K. & Drew, R. T. (1979). Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science 206, 1313-1314	[Medline]
Johnson, D. & Travis, J. (1979). The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. Journal of Biological Chemistry 254, 4022-4026	[Medline]
Keck, R. G. (1996). The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins. Analytical Biochemistry 236, 56-62	[Medline]
Kim, E., Niethammer, M., Rothschild, A., Jan, Y. N. & Sheng, M. (1995). Clustering of Shaker-type K⁺ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378, 85-88	[Medline]
Kobertz, W. R., Williams, C. & Miller, C. (2000). Hanging gondola structure of the T1 domain in a voltage-gated K⁺ channel. Biochemistry 39, 10347-10352
Kowaltowski, A. J., Castilho, R. F. & Vercesi, A. E. (1995). Ca²⁺-induced mitochondrial membrane permeabilization: role of coenzyme Q redox state. American Journal of Physiology 269, C141-147	[Medline]
Kuschel, L., Hansel, A., Schönherr, R., Weissbach, H., Brot, N., Hoshi, T. & Heinemann, S. H. (1999). Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Letters 456, 17-21	[Medline]
Lafon-Cazal, M., Pietre, S., Culcasi, M. & Bockaert, J. (1993). NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-53	[Medline]

				U. Bechtold, D. J. Murphy, and P. M. Mullineaux Arabidopsis Peptide Methionine Sulfoxide Reductase2 Prevents Cellular Oxidative Damage in Long Nights PLANT CELL, April 1, 2004; 16(4): 908 - 919. [Abstract] [Full Text] [PDF]

				J. Choi, A. I. Levey, S. T. Weintraub, H. D. Rees, M. Gearing, L.-S. Chin, and L. Li Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases J. Biol. Chem., March 26, 2004; 279(13): 13256 - 13264. [Abstract] [Full Text] [PDF]

				G. H. Coombs, G. D. Westrop, P. Suchan, G. Puzova, R. P. Hirt, T. M. Embley, J. C. Mottram, and S. Muller The Amitochondriate Eukaryote Trichomonas vaginalis Contains a Divergent Thioredoxin-linked Peroxiredoxin Antioxidant System J. Biol. Chem., February 13, 2004; 279(7): 5249 - 5256. [Abstract] [Full Text] [PDF]

				O. Yermolaieva, R. Xu, C. Schinstock, N. Brot, H. Weissbach, S. H. Heinemann, and T. Hoshi Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation PNAS, February 3, 2004; 101(5): 1159 - 1164. [Abstract] [Full Text] [PDF]

				V. K. Singh and J. Moskovitz Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress Microbiology, October 1, 2003; 149(10): 2739 - 2747. [Abstract] [Full Text] [PDF]